For all those companies wondering whether to dip their toes in the water with social media or not, this fun presentation provides some interesting stats and snippets that illustrate some useful pointers.
Well, it is summer Friday, right?
« Compliance, brown bag syndrome and pharma marketing | Main | What does Icarus Consultants do? »
July 17, 2009
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8342ae08153ef0115711db6bb970c
Listed below are links to weblogs that reference Social media monitoring and Pharma:
The comments to this entry are closed.
Publisher
- This blog is published by:
Sally Church, PhD
of Icarus Consultants, Inc.
The contents of this blog are the intellectual property of the author and all rights are reserved. No commercial use, copying or distribution is permitted without the author's express permission.
Become a Fan
What we do
Icarus Consultants is a management consulting company focusing on marketing strategy and new product development to the Pharma and Biotech industry. We focus on specialist areas such as oncology, hematology, immunology, respiratory and HIV.
Our particular areas of interest include social media monitoring, key opinion leader research, competitive intelligence and landscape opportunity assessments. We use primary qualitative market research and buzz metrics to support our strategic analyses.
Company Web Site
Follow Me
Pharma Twitter Groups
Stat Counter
Recent Comments
- Ruby Gadelrab on Pathwork Diagnostics and Novartis to pursue a research partnership
- MaverickNY on The ravages of smoking and cancer...
- Dave Hodgkinson on The ravages of smoking and cancer...
- Gregory Pawelski on Time for FDA and ODAC to decide on Avastin in breast cancer
- Gregory Pawelski on The Long Tail of Cancer Research
- MaverickNY on Simplifying data capture and blog post workflow
- Drmiggy on Monday Mumblings - Life in the fast lane
- Drpdtapp on On clinical trials, creativity and patient adherence in cancer
- twitter.com/jodyms on On clinical trials, creativity and patient adherence in cancer
- CraigLipset on On clinical trials, creativity and patient adherence in cancer
Comments